583 related articles for article (PubMed ID: 28870239)
1. Evaluating somatic tumor mutation detection without matched normal samples.
Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
[TBL] [Abstract][Full Text] [Related]
2. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Cheng DT; Mitchell TN; Zehir A; Shah RH; Benayed R; Syed A; Chandramohan R; Liu ZY; Won HH; Scott SN; Brannon AR; O'Reilly C; Sadowska J; Casanova J; Yannes A; Hechtman JF; Yao J; Song W; Ross DS; Oultache A; Dogan S; Borsu L; Hameed M; Nafa K; Arcila ME; Ladanyi M; Berger MF
J Mol Diagn; 2015 May; 17(3):251-64. PubMed ID: 25801821
[TBL] [Abstract][Full Text] [Related]
3. ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.
Kalatskaya I; Trinh QM; Spears M; McPherson JD; Bartlett JMS; Stein L
Genome Med; 2017 Jun; 9(1):59. PubMed ID: 28659176
[TBL] [Abstract][Full Text] [Related]
4. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing.
Wei L; Papanicolau-Sengos A; Liu S; Wang J; Conroy JM; Glenn ST; Brese E; Hu Q; Miles KM; Burgher B; Qin M; Head K; Omilian AR; Bshara W; Krolewski J; Trump DL; Johnson CS; Morrison CD
BMC Med Genomics; 2016 Oct; 9(1):64. PubMed ID: 27756300
[TBL] [Abstract][Full Text] [Related]
7. A cancer cell-line titration series for evaluating somatic classification.
Denroche RE; Mullen L; Timms L; Beck T; Yung CK; Stein L; McPherson JD; Brown AM
BMC Res Notes; 2015 Dec; 8():823. PubMed ID: 26708082
[TBL] [Abstract][Full Text] [Related]
8. Shimmer: detection of genetic alterations in tumors using next-generation sequence data.
Hansen NF; Gartner JJ; Mei L; Samuels Y; Mullikin JC
Bioinformatics; 2013 Jun; 29(12):1498-503. PubMed ID: 23620360
[TBL] [Abstract][Full Text] [Related]
9. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
10. A method to reduce ancestry related germline false positives in tumor only somatic variant calling.
Halperin RF; Carpten JD; Manojlovic Z; Aldrich J; Keats J; Byron S; Liang WS; Russell M; Enriquez D; Claasen A; Cherni I; Awuah B; Oppong J; Wicha MS; Newman LA; Jaigge E; Kim S; Craig DW
BMC Med Genomics; 2017 Oct; 10(1):61. PubMed ID: 29052513
[TBL] [Abstract][Full Text] [Related]
11. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data.
do Valle ÍF; Giampieri E; Simonetti G; Padella A; Manfrini M; Ferrari A; Papayannidis C; Zironi I; Garonzi M; Bernardi S; Delledonne M; Martinelli G; Remondini D; Castellani G
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):341. PubMed ID: 28185561
[TBL] [Abstract][Full Text] [Related]
12. FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
Kim H; Lee AJ; Lee J; Chun H; Ju YS; Hong D
Genome Med; 2019 Dec; 11(1):81. PubMed ID: 31847917
[TBL] [Abstract][Full Text] [Related]
13. Comparing somatic mutation-callers: beyond Venn diagrams.
Kim SY; Speed TP
BMC Bioinformatics; 2013 Jun; 14():189. PubMed ID: 23758877
[TBL] [Abstract][Full Text] [Related]
14. Combination of RNA- and exome sequencing: Increasing specificity for identification of somatic point mutations and indels in acute leukaemia.
Hansen MC; Herborg LL; Hansen M; Roug AS; Hokland P
Leuk Res; 2016 Dec; 51():27-31. PubMed ID: 27821287
[TBL] [Abstract][Full Text] [Related]
15. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
[TBL] [Abstract][Full Text] [Related]
16. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.
Bourgon R; Lu S; Yan Y; Lackner MR; Wang W; Weigman V; Wang D; Guan Y; Ryner L; Koeppen H; Patel R; Hampton GM; Amler LC; Wang Y
Clin Cancer Res; 2014 Apr; 20(8):2080-91. PubMed ID: 24573554
[TBL] [Abstract][Full Text] [Related]
17. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
[TBL] [Abstract][Full Text] [Related]
18. isma: an R package for the integrative analysis of mutations detected by multiple pipelines.
Di Nanni N; Moscatelli M; Gnocchi M; Milanesi L; Mosca E
BMC Bioinformatics; 2019 Feb; 20(1):107. PubMed ID: 30819096
[TBL] [Abstract][Full Text] [Related]
19. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
[TBL] [Abstract][Full Text] [Related]
20. Mutascope: sensitive detection of somatic mutations from deep amplicon sequencing.
Yost SE; Alakus H; Matsui H; Schwab RB; Jepsen K; Frazer KA; Harismendy O
Bioinformatics; 2013 Aug; 29(15):1908-9. PubMed ID: 23712659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
